ReWalk Robotics Ltd. (NASDAQ:RWLK – Get Rating)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.89 and traded as high as $0.94. ReWalk Robotics shares last traded at $0.94, with a volume of 262,144 shares traded.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on RWLK shares. HC Wainwright boosted their price objective on ReWalk Robotics from $2.50 to $3.00 and gave the stock a “buy” rating in a research report on Tuesday, November 15th. StockNews.com began coverage on shares of ReWalk Robotics in a research report on Monday, October 17th. They set a “sell” rating on the stock.
ReWalk Robotics Stock Up 6.6 %
The business has a fifty day simple moving average of $0.89 and a 200 day simple moving average of $0.95. The company has a market cap of $58.21 million, a price-to-earnings ratio of -3.24 and a beta of 2.39.
Insider Buying and Selling
Hedge Funds Weigh In On ReWalk Robotics
A number of institutional investors have recently made changes to their positions in the business. Renaissance Technologies LLC grew its stake in ReWalk Robotics by 13.7% during the 3rd quarter. Renaissance Technologies LLC now owns 109,600 shares of the medical device company’s stock worth $97,000 after buying an additional 13,200 shares during the last quarter. Millennium Management LLC grew its stake in shares of ReWalk Robotics by 78.6% in the second quarter. Millennium Management LLC now owns 138,282 shares of the medical device company’s stock worth $130,000 after purchasing an additional 60,859 shares in the last quarter. Finally, Advisor Group Holdings Inc. grew its stake in shares of ReWalk Robotics by 12.2% in the first quarter. Advisor Group Holdings Inc. now owns 1,038,207 shares of the medical device company’s stock worth $1,204,000 after purchasing an additional 112,875 shares in the last quarter. 4.98% of the stock is owned by institutional investors and hedge funds.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.
- Get a free copy of the StockNews.com research report on ReWalk Robotics (RWLK)
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.